TNF and inflammatory bowel disease: We can schematically distinguish the predicting elements of efficacy for anti-TNF-α agents in IBD patients in three groups: (1) patient-related factors; (2) disease-related factors (i.e., the specific features of the disease); (3) treatment-related factors.